Theradvisor EI was founded in 2022, with the goal of helping scientists from pharma industry, biotech companies, and academia to understand pharmacology and drug design and accelerate drug discovery.
Theradvisor EI is led by Ph.D. level scientists with brood expertise in medicinal chemistry, molecular and cellular biology, in vivo studies and translational sciences. We have some emphasis on the development of radiopharmaceutical molecules for imaging and radioligand therapy but we would be happy to help you on any scientific or technical project.
Theradvisor EI is a registered company in France.
SIREN: 913 033 726
SIRET: 913 033 726 00013
NAF/APE: 74.90B – Activités spécialisées, scientifiques et techniques diverses* Theradvisor EI is not subject to VAT in agreement with article 293B of CGI *